SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the pricing of its public offering of 5,700,000 shares of common stock at $25.50 per share. The offering is expected to close on or about April 22, 2008. Gross proceeds from the offering will be approximately $145.4 million. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $600.0 million unsecured line of credit and for other general corporate and working capital purposes. All of the shares are being sold by the company.
The underwriters for the offering are Raymond James & Associates, Inc., Morgan Stanley & Co. Incorporated, Wachovia Capital Markets, LLC, KeyBanc Capital Markets Inc., Robert W. Baird & Co. Incorporated, Credit Suisse Securities (USA) LLC, RBC Capital Markets Corporation and Stifel, Nicolaus & Company, Incorporated. BioMed has also granted the underwriters a 30-day option to purchase up to an additional 855,000 shares to cover over-allotments, if any.
The registration statement relating to these securities has become
effective by rule of the Securities and Exchange Commission. This press
release shall not constitute an offer to sell or the solicitation of an
offer to buy any of BioMed's common stock, nor shall there be any sale of
such common stock in any state in which such offer, solicitation, or sale
would be unlawful prior to registration or qualification under the
securities laws of such state. The offering of BioMed's common stock will
be made only by means of a prospectus and a related prospectus supplement,
copies of which, when available, may be obtained by contacting Raymond
James & Associates, Inc., 880 Carillon Parkway, St. Petersbur
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2008 PR Newswire.
All rights reserved